IVC SYSTEM

K040317 · Mark H. Friedman · ILO · May 7, 2004 · Physical Medicine

Device Facts

Record IDK040317
Device NameIVC SYSTEM
ApplicantMark H. Friedman
Product CodeILO · Physical Medicine
Decision DateMay 7, 2004
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 890.5720
Device ClassClass 2
AttributesTherapeutic

Indications for Use

To be used for cooling therapy when applied to the affected body surface during a migraine headache and for the reduction of pain from muscle spasms associated with migraine headaches.

Device Story

IVC™ (In Vitro Chilling) device provides localized cooling therapy. Applied to affected body surface; used for migraine headache relief and reduction of pain from associated muscle spasms. Operates as a water circulating hot or cold pack. Used in clinical or home settings; applied by patient or clinician. Provides therapeutic cooling to mitigate pain symptoms.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Water circulating hot or cold pack. Class II exempt device under 21 CFR 890.5720. Product code ILO.

Indications for Use

Indicated for patients experiencing migraine headaches requiring cooling therapy and reduction of pain from associated muscle spasms.

Regulatory Classification

Identification

A water circulating hot or cold pack is a device intended for medical purposes that operates by pumping heated or chilled water through a plastic bag and that provides hot or cold therapy for body surfaces.

Special Controls

*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 890.9.

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ## DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/0/Picture/1 description: The image shows the words "Public Health Service" in bold, black font. The words are stacked on one line. The text appears to be extracted from a document or sign. Image /page/0/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the circle is an abstract symbol that resembles an eagle or bird in flight. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 JUN 7 - 2004 Mark H. Friedman, DDS Westchester Head & Neck Pain Center 2 Overhill Road, Suite 260 Scarsdale, New York 10583 Re: K040317 Trade Name: IVC™ device Classification Regulation Name and Number: Water circulating hot or cold pack 21 CFR § 890.5720 Regulatory Class: Class II Exempt Product Code: ILO Dated: January 26, 2004 Received: February 9, 2004 Dear Dr. Friedman: This letter corrects our exempt letter of May 7, 2004 regarding the IVC™ device. We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050. {1}------------------------------------------------ ## Page 2 - Mark H. Friedman, DDS This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, J. Mark A. Wilkerson Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## XII. Indication for Use: [Separate page] 510(k) Number: NA Device Name: IVCTM (In Vitro Chilling) device. ## Indications for Use: 1. To be used for cooling therapy when applied to the affected body surface during a migraine headache and for the reduction of pain from muscle spasms associated with migraine headaches. (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use X (Per 21 CFR 801.109) Mark N. Milham Sion Sign Jivision of General, Restorative, and Neurological Devices . or Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________ (Optional Format 1-2-96) Rep.p. 9 9 10 **510(k) Number** K040317
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...